Manufacturer CAS 536759-91-8 Apixaban Intermediate Apixaban Impurity

Model NO.
01-1
Stock
2.00kg
Water
0.01%
Capacity
25000kg
Annul Sales
2000kg
Volume
200kg
Experience
10years
Ever Exported?
Yes
Market
India
Heavy Metal
10ppm
Application
for Antibacteria
Residual Solvent
Ethanol
Impurity
0.01%
Other Name
(Arry-470)
Sample
Free
Intermediate
Apixaban-2
Transport Package
Air
Specification
JP
Trademark
jianfeng
Origin
Shandong
HS Code
2939000000
Production Capacity
400kg
Reference Price
$ 4.68 - 81.00
Contact Us

Product Description

1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester503614-91-3Apixaban intermediate
Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester27143-07-3Apixaban intermediate
2(1H)-pyridine,3-chloro-5,6-dihydro-1-(4-nitrophenyl)536760-29-9Apixaban intermediate
3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro-1H-pyridin-2-one545445-44-1Apixaban intermediate
3-(4-Morpholinyl)-1-(4-nitrophenyl)-5,6-dihydro-2(1H)-pyridinone503615-03-0Apixaban intermediate
Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3536759-91-8Apixaban intermediate
ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate503615-07-4Apixaban intermediate
1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone1267610-26-3Apixaban intermediate

Manufacturer CAS 536759-91-8 Apixaban Intermediate Apixaban ImpurityA key component in helping our customers be first to market is a responsive supply chain. We achieve this by making sure that all our facilities are operating efficiently and to the latest standards of quality, safety, and productivity. A strong interconnect between business and factories allows for a quick reaction to dynamic market changes, so that we can avert shortages and meet sudden surges in demand.
Apixaban is a selective inhibitor of FXa. It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound FXa, and prothrombinase activity. Apixaban has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa, apixaban decreases thrombin generation and thrombus development

 

Pharmaceutical Intermediate

PNEUTEC.IT, 2023